Recursion Pharmaceuticals Inc Cl A (NQ: RXRX )
9.260
-0.180
(-1.91%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 14, 2024
Add to My Watchlist
Headline News about Recursion Pharmaceuticals Inc Cl A
![](https://cdn.benzinga.com/files/images/story/2024/04/24/Jim-Cramer-Photo-by-s-bukley-on-Shutters.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
Via Talk Markets
![](https://g.foolcdn.com/editorial/images/771188/two-investors-look-at-figures.jpg)
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Analyst Scoreboard: 5 Ratings For Recursion Pharmaceuticals
April 09, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/03/cathie-wood-stocks-1600.png)
![](https://images.pexels.com/photos/5849595/pexels-photo-5849595.jpeg?auto=compress&cs=tinysrgb&dpr=1&w=500)
![](https://cdn.benzinga.com/files/images/story/2024/04/11/cathie-wood-bz-ark.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/772140/scientists-looking-at-screen-with-icons.jpg)
![](https://g.foolcdn.com/editorial/images/771562/doctor-explains-situation-to-colleagues.jpg)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
AI Surge Ending: Only One Category Was Up This Week
April 06, 2024
Via Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
![](https://g.foolcdn.com/editorial/images/771447/person-sitting-and-working-at-a-desk.jpg)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://cdn.benzinga.com/files/images/story/2024/cathie-wood-bz-ark_9.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/Artificial-Intelligence-Photo-by-Pixels-_4.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/Moderna-COVID-19-vaccine-2021-G_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/Jensen-Huang_0.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/768100/two-scientists-work-at-lab-bench-with-scope.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/small-cap-1600-1024x576.png)
![](https://cdn.benzinga.com/files/images/story/2024/03/13/image33.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/07/healthcare1600.jpg)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://investorplace.com/wp-content/uploads/2021/03/biotech-stocks-2.jpg)
![](https://g.foolcdn.com/editorial/images/767342/person-in-a-lab-looking-through-a-microscope.jpg)
Why Recursion Pharmaceuticals Stock Dived by Nearly 17% Today
February 28, 2024
Via The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
![](https://cdn.benzinga.com/files/images/story/2024/02/28/image21.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/02/28/image36.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/02/28/image34.jpeg?width=1200&height=800&fit=crop)
3D Systems Posts Downbeat Q4 Results, Joins Eventbrite, Lemonade And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
February 28, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.